Women’s Cancer Screening: Equity & Access Issues
- Breast cancer remains a leading cause of cancer death for women in the U.S., with estimates projecting over 40,000 deaths in 2025, according to the American Cancer Society.
- While overall breast cancer mortality rates have declined, disparities persist.
- Cervical cancer mortality has also decreased due to Pap tests and HPV vaccinations.
Breast and cervical cancer screening saves lives; though, stark inequities persist.This vital fact underscores the urgent need addressed in our latest report: Black women face disproportionately high breast cancer mortality, while rural women frequently enough encounter late-stage diagnoses due to limited access to care. These disparities highlight critical challenges within women’s healthcare. The availability of preventative screenings,like mammograms and HPV vaccinations,directly impacts outcomes,yet access varies significantly. policymakers must act to improve access to breast cancer screening and cervical cancer screening. The Affordable Care Act’s preventative care provisions are under review, and this poses a threat to progress. News Directory 3 provides insightful data and analysis on this critical issue. Discover what’s next for cancer screening equity and how you can help close these gaps.
Disparities Persist in Breast and Cervical Cancer Screening
Updated June 03, 2025
Breast cancer remains a leading cause of cancer death for women in the U.S., with estimates projecting over 40,000 deaths in 2025, according to the American Cancer Society. The CDC reports approximately 11,500 new cervical cancer cases annually, resulting in 4,000 deaths. However, regular cancer screening offers a significant chance for prevention.
While overall breast cancer mortality rates have declined, disparities persist. Non-Hispanic Black women experience the highest mortality rates,frequently enough diagnosed with more aggressive cancers at younger ages. Women in rural areas also face increased risks of late-stage diagnosis, contrasting with the national trend.
Cervical cancer mortality has also decreased due to Pap tests and HPV vaccinations. Even so, Black women and rural women still have disproportionately high death rates. The National Cancer Institute notes that most cervical cancers stem from HPV infections, making them largely preventable through vaccination and screening.
Disparities in access to care contribute substantially to these mortality differences. Black women frequently enough face late-stage diagnoses, screening barriers, and unequal treatment access. Rural women,nonetheless of race,have less access to mammograms and cervical cancer screening.A significant percentage of U.S. counties are considered “maternal care deserts,” lacking obstetric providers who also offer preventative cancer screenings.
HPV vaccination, recommended for women aged 11 to 26, is a key preventative measure. However, vaccination rates vary by state, with rural and uninsured populations less likely to be vaccinated and screened, increasing their risk of late-stage diagnosis.
Addressing these disparities requires tackling complex racial, geographic, and economic inequalities. Mobile mammography clinics and interventions focused on increasing access to care have shown promise in reaching underserved populations.
The Affordable care Act (ACA) significantly reduced the number of uninsured Americans and mandates coverage for preventative screenings like mammograms and cervical cancer screenings at no cost to the patient.Though, this requirement is under review by the Supreme Court, potentially exacerbating existing health disparities if preventative services are no longer fully covered.
What’s next
Policymakers, payers, and providers must prioritize accessible screening programs to reach high-risk groups and reduce mortality disparities in breast cancer and cervical cancer.